Arcturus Therapeutics Holdings, Inc. (ARCT)
15.19
-0.98
(-6.06%)
USD |
NASDAQ |
Aug 28, 16:00
15.18
-0.01
(-0.07%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Total Liabilities (Quarterly) : 52.50M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.50M |
| March 31, 2026 | 54.05M |
| December 31, 2025 | 57.16M |
| September 30, 2025 | 57.78M |
| June 30, 2025 | 78.22M |
| March 31, 2025 | 98.03M |
| December 31, 2024 | 103.09M |
| September 30, 2024 | 108.79M |
| June 30, 2024 | 130.02M |
| March 31, 2024 | 154.88M |
| December 31, 2023 | 150.89M |
| September 30, 2023 | 177.59M |
| June 30, 2023 | 145.47M |
| March 31, 2023 | 141.62M |
| December 31, 2022 | 180.08M |
| September 30, 2022 | 147.96M |
| June 30, 2022 | 166.30M |
| March 31, 2022 | 157.24M |
| December 31, 2021 | 164.60M |
| September 30, 2021 | 175.41M |
| June 30, 2021 | 143.16M |
| March 31, 2021 | 128.86M |
| December 31, 2020 | 79.90M |
| September 30, 2020 | 60.89M |
| June 30, 2020 | 56.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 55.12M |
| December 31, 2019 | 56.35M |
| September 30, 2019 | 51.32M |
| June 30, 2019 | 49.32M |
| March 31, 2019 | 38.06M |
| December 31, 2018 | 30.56M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 18.23M |
| September 30, 2017 | 2.296M |
| June 30, 2017 | 1.657M |
| March 31, 2017 | 2.19M |
| December 31, 2016 | 4.34M |
| September 30, 2016 | 3.295M |
| June 30, 2016 | 2.907M |
| March 31, 2016 | 2.11M |
| December 31, 2015 | 2.352M |
| September 30, 2015 | 2.564M |
| June 30, 2015 | 2.864M |
| March 31, 2015 | |
| December 31, 2014 | 2.375M |
| September 30, 2014 | 4.905M |
| June 30, 2014 | 4.753M |
| March 31, 2014 | 3.346M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Exelixis, Inc. | 650.47M |
| PTC Therapeutics, Inc. | 3.416B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 224.31M |
| Shareholders Equity (Quarterly) | 171.81M |
| Debt to Equity Ratio | 0.1335 |
| Current Ratio | 5.879 |
| Net Debt Paydown Yield | 2.07% |